- Home
- KPRX vs TGHL Comparison
KPRX vs TGHL Comparison
Compare KPRX & TGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPRX | TGHL |
|---|---|---|
| Founded | 1998 | 2020 |
| Country | United States | Singapore |
| Employees | N/A | 7 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6M | 11.9M |
| IPO Year | 2014 | 2024 |
Fundamental Metrics
Financial Performance| Metric | KPRX | TGHL |
|---|---|---|
| Price | $1.42 | $0.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 53.4K | ★ 73.7K |
| Earning Date | 11-17-2026 | 12-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.55 | $0.27 |
| 52 Week High | $2.91 | $2.48 |
Technical Indicators
Market Signals| Indicator | KPRX | TGHL |
|---|---|---|
| Relative Strength Index (RSI) | 21.89 | 34.56 |
| Support Level | N/A | $0.39 |
| Resistance Level | $2.63 | $0.50 |
| Average True Range (ATR) | 0.17 | 0.05 |
| MACD | -0.07 | -0.00 |
| Stochastic Oscillator | 2.56 | 14.24 |
Price Performance
Historical ComparisonAbout KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About TGHL The GrowHub Limited Class A Ordinary Shares
The Growhub Ltd operates as the intersection of technology and supply chain management in the food industry, focusing on enhancing product traceability and authenticity. With a commitment to innovation and sustainability, the company has developed a multi-faceted approach to address industry challenges. Its business currently comprises two main divisions, which are the Traceability and Authenticity Solutions and Carbon Project Development.